Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 8/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9567491 | 1.00 | NFE2L2 (0.52) | NFE2L2PTGS1APPHSD11B1NQO2 | |
| SCHEMBL2459029 | 0.83 | ALDH1A1 (0.39) | — | |
| SCHEMBL2459032 | 0.83 | ALDH1A1 (0.39) | — | |
| SCHEMBL9567521 | 0.78 | NFE2L2 (0.50) | NFE2L2PTGS1ALOX5PTGS2FBP1 | |
| SCHEMBL9567576 | 0.78 | RAB9A (0.44) | — | |
| SCHEMBL9567524 | 0.78 | NFE2L2 (0.50) | NFE2L2PTGS1ALOX5PTGS2FBP1 | |
| SCHEMBL9567577 | 0.78 | RAB9A (0.44) | — | |
| SCHEMBL9567534 | 0.78 | AHR (0.50) | NFE2L2PTGS1ALOX5PTGS2FBP1 | |
| SCHEMBL9567531 | 0.78 | AHR (0.50) | NFE2L2PTGS1ALOX5PTGS2FBP1 | |
| SCHEMBL22468800 | 0.78 | NFE2L2 (0.78) | NFE2L2PTGS1APPHSD11B1NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0575923-A1 | Triazole Derivatives | Ikeda Mohando Co., Ltd. (JP) | 1993-12-29 | — | — | EP | disclosed |